Prognostic importance of FGF2 and FGFR1 expression for patients affected by ameloblastoma.

Flávia Sirotheau Correa PontesBernar Monteiro BenitesCiro Dantas SoaresThayná Melo de Lima MoraisGleyson Kleber do Amaral-SilvaOslei Paes de AlmeidaFernando Augusto SoaresEduardo Rodrigues Fregnani

Published in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2018)

Cytoplasmic expression of FGF2 and FGF2 + FGFR1 is associated with ameloblastoma recurrence, but FGF2 and FGFR1 are not determinants of a lower DFS.

Keyphrases

poor prognosis
end stage renal disease
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
long non coding rna
patient reported outcomes
free survival